• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Commun Biol . FPR1 signaling aberrantly regulates S100A8/A9 production by CD14+FCN1hi macrophages and aggravates pulmonary pathology in severe COVI

tetano

Editor, Senior Moderator
Commun Biol


. 2024 Oct 14;7(1):1321.
doi: 10.1038/s42003-024-07025-4. FPR1 signaling aberrantly regulates S100A8/A9 production by CD14[SUP]+[/SUP]FCN1[SUP]hi[/SUP] macrophages and aggravates pulmonary pathology in severe COVID-19

Zhongyi Wang[SUP] #[/SUP][SUP] 1 [/SUP], Yi Wang[SUP] #[/SUP][SUP] 1 [/SUP], Qing Yan[SUP] #[/SUP][SUP] 1 [/SUP], Changlin Cai[SUP] 1 [/SUP], Ying Feng[SUP] 1 [/SUP], Qinghan Huang[SUP] 1 [/SUP], Ting Li[SUP] 1 [/SUP], Shenzhen Yuan[SUP] 1 [/SUP], Juan Huang[SUP] 2 [/SUP], Zhi-Hui Luo[SUP] 3 [/SUP], Jingjiao Zhou[SUP] 4 [/SUP]



Affiliations
Abstract

Excessive alarmins S100A8/A9 escalate the inflammation and even exacerbate immune-driven thrombosis and multi-organ damage. However, the regulatory mechanisms of S100A8/A9 expression in infectious diseases remain unclear. In this study, high-dimensional transcriptomic data analyses revealed a high proportion of CD14[SUP]+[/SUP]FCN1[SUP]hi[/SUP] macrophages within the pulmonary niche post-severe SARS-CoV-2 infection. By constructing the S100-coexpression gene list and supervised module scoring, we found that CD14[SUP]+[/SUP]FCN1[SUP]hi[/SUP] macrophages presented the highest scores of alarmin S100, and possibly served as the trigger and amplifier of inflammation in severe COVID-19. These CD14[SUP]+[/SUP]FCN1[SUP]hi[/SUP] cells lacked the positive regulatory activity of transcription factor PPARγ, and lost their differentiation ability towards mature macrophages. Ex vivo experiments further validated that the epithelial cells with high ORF-3a expression promoted the expression and secretion of S100A8/A9 through ANXA1/SAA1-FPR1 signaling. S100A8/A9 heterodimers, as well as the co-localization of S100A8/A9 with microtubules, were both diminished by the FPR1 inhibitor. Phospho-kinase protein array indicated that STAT3 promoted transcription, and PLC-γ and ERK1/2 pathways were involved in the hetero-dimerization and unconventional secretion of S100A8/A9. Our study highlights the pivotal role of FPR1 signaling in the excessive production of S100A8/A9 and provides a promising target for the prevention and control of severe COVID-19 and post-acute COVID-19 sequelae.


 
Back
Top Bottom